Calendar of Events
Prev MonthPrev Month Next MonthNext Month
San Antonio Breast Cancer Conference Update 2021
Thursday, March 04, 2021, 7:00 PM EST
Category: Events

Join us for the SAN ANTONIO BREAST CANCER CONFERENCE UPDATE in Collaboration with the Maryland Breast Cancer Coalition.

Thursday, March 4, 2021, 7pm
on the Horizon Virtual Venue
Program followed by Reception

Register HERE.
Click HERE to download the flyer below.

Speaker: Angela DeMichele, MD, MSCE

Dr. DeMichele is a Professor of Medicine  at the University of Pennsylvania and holds the Jill and Alan Miller Endowed Professorship in Breast Cancer Excellence. She earned an M.S. in Biochemistry at Brown University, an M.D. at Washington University School of Medicine, where she was a 4-School Physician/Scientist Scholar, and an MSCE at the University of Pennsylvania.  She completed her residency in Internal Medicine, fellowship in Hematology/Oncology and post-doctoral training in Clinical Epidemiology at the University of Pennsylvania, before joining the faculty in 2000.  She has been the Co-Leader of the Breast Cancer Research Program in the Abramson Cancer Center since 2005, where she also directs both the Breast Cancer Clinical Trials Program and the Breast Cancer TRACR Biobank. 

Dr. DeMichele’s research program is focused on drug development, innovative clinical trial design and investigation of biomarkers for precision therapy.  As Co-Director of Penn’s  2-PREVENT Breast Cancer Translational Center of Excellence, she leads a multidisciplinary team to tackle the problem of breast cancer recurrence through novel clinical trials targeting disseminated and circulating tumor cells, and developing new assays to detect and characterize circulating tumor and dormant cancer cells.  She also leads clinical research teams as Co-Chair of the Breast Committee of the ECOG/ACRIN Cooperative Group, Trial Operations Chair of the I-SPY2 multicenter, neoadjuvant trial, and Penn PI for the Translational Breast Cancer Research Consortium. She has played a pivotal role in the development of numerous targeted therapies, including phase I and II development of the CDK4/6 inhibitor, Palbociclib and is currently co-PI of two international trials: the PALLAS Adjuvant Trial and PATINA Trial for Her2+ disease. She currently holds an R01 from the NCI to fund an innovative clinical trial targeting minimal residual disease to reduce recurrence.  Her research is has been funded by the NIH, NCI, DOD, Komen Foundation, Breast Cancer Research Foundation, American Society of Clinical Oncology, American Cancer Society and other philanthropic sources. She has authored over 150 publications in high impact journals such as the New England Journal of Medicine and Journal of the American Medical Association (JAMA), and serves on numerous editorial boards. She has held leadership positions in several international societies, including Chairing the Metastatic Breast Cancer Scientific Program and Breast Cancer and Clinical Trials Education Committees of the American Society of Clinical Oncology, and serves on the Executive Committee and Program Committee for the San Antonio Breast Cancer Symposium.  She also sits on numerous national committees including the ASCO Guidelines Advisory Committee and the NCCN Clinical Research Steering Committee.  She previously served as Physician Secretary on the American Board of Internal Medicine Oncology Subspecialty Board.

Dr. DeMichele also maintains an active breast oncology practice, where she is sought nationally for consultative service.  Her clinical excellence has been recognized in Philadelphia Magazine’s Top Docs since 2017.   She has extensive experience in teaching at all levels of medical education.  She previously led the Doris Duke Clinical Research Fellowship at the University of Pennsylvania, training generations of medical students to pursue careers in clinical research, and has mentored over 20 pre- and post-doctoral trainees, in addition to teaching medical students in clinical oncology for over 20 years. She previously developed and directed EP650, a graduate course on Clinical Trials and Translational Research in the Perelman School of Medicine and has served as Clinical Epidemiology Thesis Advisor to numerous Masters and PhD candidates.